Segui
Mark L Ormiston
Mark L Ormiston
Associate Professor and Tier II Canada Research Chair
Email verificata su queensu.ca - Home page
Titolo
Citata da
Citata da
Anno
Pulmonary arterial hypertension: pathogenesis and clinical management
T Thenappan, ML Ormiston, JJ Ryan, SL Archer
Bmj 360, 2018
7712018
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension
L Long, ML Ormiston, X Yang, M Southwood, S Gräf, RD Machado, ...
Nature medicine 21 (7), 777-785, 2015
4722015
Identification of microRNA-124 as a major regulator of enhanced endothelial cell glycolysis in pulmonary arterial hypertension via PTBP1 (polypyrimidine tract binding protein …
P Caruso, BJ Dunmore, K Schlosser, S Schoors, C Dos Santos, ...
Circulation 136 (25), 2451-2467, 2017
2122017
Single-cell hydrogel encapsulation for enhanced survival of human marrow stromal cells
G Karoubi, ML Ormiston, DJ Stewart, DW Courtman
Biomaterials 30 (29), 5445-5455, 2009
1472009
MicroRNA-138 and microRNA-25 down-regulate mitochondrial calcium uniporter, causing the pulmonary arterial hypertension cancer phenotype
Z Hong, KH Chen, A DasGupta, F Potus, K Dunham-Snary, S Bonnet, ...
American journal of respiratory and critical care medicine 195 (4), 515-529, 2017
1452017
Epigenetic dysregulation of the dynamin-related protein 1 binding partners MiD49 and MiD51 increases mitotic mitochondrial fission and promotes pulmonary arterial hypertension …
KH Chen, A Dasgupta, J Lin, F Potus, S Bonnet, J Iremonger, J Fu, ...
Circulation 138 (3), 287-304, 2018
1232018
Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension
ML Ormiston, C Chang, LL Long, E Soon, D Jones, R Machado, C Treacy, ...
Circulation 126 (9), 1099-1109, 2012
1232012
Proteomic analysis implicates translationally controlled tumor protein as a novel mediator of occlusive vascular remodeling in pulmonary arterial hypertension
JR Lavoie, ML Ormiston, C Perez-Iratxeta, DW Courtman, B Jiang, ...
Circulation 129 (21), 2125-2135, 2014
942014
Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension
ML Ormiston, Y Deng, DJ Stewart, DW Courtman
American journal of respiratory cell and molecular biology 43 (5), 546-554, 2010
902010
Generation and culture of blood outgrowth endothelial cells from human peripheral blood
ML Ormiston, MR Toshner, FN Kiskin, CJZ Huang, E Groves, NW Morrell, ...
JoVE (Journal of Visualized Experiments), e53384, 2015
802015
Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities
S Jafri, ML Ormiston
American Journal of Physiology-Regulatory, Integrative and Comparative …, 2017
722017
A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells
I Geti, ML Ormiston, F Rouhani, M Toshner, M Movassagh, J Nichols, ...
Stem cells translational medicine 1 (12), 855-865, 2012
712012
Transcript analysis reveals a specific HOX signature associated with positional identity of human endothelial cells
M Toshner, BJ Dunmore, EF McKinney, M Southwood, P Caruso, ...
PloS one 9 (3), e91334, 2014
642014
TGF-β and IL-15 synergize through MAPK pathways to drive the conversion of human NK cells to an innate lymphoid cell 1–like phenotype
LG Hawke, BZ Mitchell, ML Ormiston
The Journal of Immunology 204 (12), 3171-3181, 2020
522020
A potential role for exosomal translationally controlled tumor protein export in vascular remodeling in pulmonary arterial hypertension
E Ferrer, BJ Dunmore, D Hassan, ML Ormiston, S Moore, J Deighton, ...
American journal of respiratory cell and molecular biology 59 (4), 467-478, 2018
472018
Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension
BE Garfield, A Crosby, D Shao, P Yang, C Read, S Sawiak, S Moore, ...
Thorax 74 (2), 164-176, 2019
462019
The enzymatic degradation of hyaluronan is associated with disease progression in experimental pulmonary hypertension
ML Ormiston, GRD Slaughter, Y Deng, DJ Stewart, DW Courtman
American Journal of Physiology-Lung Cellular and Molecular Physiology 298 (2 …, 2010
452010
Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling
AL Theilmann, LG Hawke, LR Hilton, MKM Whitford, DV Cole, JL Mackeil, ...
Arteriosclerosis, Thrombosis, and Vascular Biology 40 (11), 2605-2618, 2020
372020
Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients
SN Selvam, LJ Casey, ML Bowman, LG Hawke, AJ Longmore, J Mewburn, ...
Blood Coagulation & Fibrinolysis 28 (7), 521-533, 2017
332017
Spontaneous pulmonary hypertension in genetic mouse models of natural killer cell deficiency
MT Rätsep, SD Moore, S Jafri, M Mitchell, HJM Brady, O Mandelboim, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 315 (6 …, 2018
322018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20